Former Chief of Research and Development · Passage BIO, Inc. (PASG)

Eliseo Salinas

FY2021 is the first fiscal year CompBrief holds for Eliseo Salinas as a named executive officer of Passage BIO; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$6,550,665

Salary $357,918Stock awards $1,885,000Bonus $100,000

1st of 3 named executive officers at Passage BIO by FY2021 total.

3 named officers on file for Passage BIO, FY2021

Eliseo Salinas’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • PASG’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Passage BIO’s whole pay program stands against its peers

  • Passage BIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PASG→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 14, 2022 (DEF 14A).

Free

Get Eliseo Salinas’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Eliseo Salinas compensation by year

Passage BIO Summary Compensation Table · the one fiscal year held
In US dollars, as Passage BIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$357,918
Bonus$100,000
Stock awards$1,885,000
Option awards$4,073,901
Non-equity incentive$132,877
Pension and deferred compensation$0
All other$969
Total$6,550,665

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Passage BIO, Inc. DEF 14A filed April 14, 2022, accession 0001104659-22-046024, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Passage BIO, Inc. filed document, accession 0001104659-22-046024. Every figure is read from that document and cited to the page and table it appears in. Filed April 14, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU60,000$381,000—
Option275,000—$18.85

Per the Outstanding Equity Awards at Fiscal Year-End table in Passage BIO, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Passage BIO’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Eliseo Salinas · this pageFormer Chief of Research and Development$6,550,665
Bruce GoldsmithChief Executive Officer and President$5,288,384
Jill QuigleyFormer Chief Operating Officer$3,590,500

The full Passage BIO compensation record

free company brief

This page is one person within Passage BIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Passage BIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Eliseo Salinas's compensation dossier · One-time report. No refunds.